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Abstract
New approaches to evidence synthesis, which use human effort and machine automation in mutually reinforcing ways, can enhance the
feasibility and sustainability of living systematic reviews. Human effort is a scarce and valuable resource, required when automation is
impossible or undesirable, and includes contributions from online communities (‘‘crowds’’) as well as more conventional contributions
from review authors and information specialists. Automation can assist with some systematic review tasks, including searching, eligibility
assessment, identification and retrieval of full-text reports, extraction of data, and risk of bias assessment. Workflows can be developed in
which human effort and machine automation can each enable the other to operate in more effective and efficient ways, offering substantial
enhancement to the productivity of systematic reviews. This paper describes and discusses the potentialdand limitationsdof new ways of
undertaking specific tasks in living systematic reviews, identifying areas where these human/machine ‘‘technologies’’ are already in use,
and where further research and development is needed. While the context is living systematic reviews, many of these enabling technologies
apply equally to standard approaches to systematic reviewing.  2017 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
This is the second paper in a series of papers discus-
sing the emerging field of living systematic reviews
(Box 1). In this paper, we specifically focus on the ways
in which the use of new human and machine ‘‘technolo-
gies’’ can make the standard systematic review process
more efficient.
Systematic reviews are a type of literature review, which
adopt principles of scientific method to the task of finding
and summarizing research. They aim to answer prespecified
research questions using all relevant empirical evidence,
using explicit and replicable methods and minimizing bias.
They thus aim to provide trustworthy findings on which
policy and practice decisions can be made [1]. A living sys-
tematic review is a systematic review which is continually
updated in the light of new evidence as it becomes available
(Box 2) [2]. Living systematic reviews represent an oppor-
tunity to rethink conventional review processes and take
advantage of emerging approaches to reviewing which
promise to increase efficiency [3]. In this paper, we
describe how new ‘‘technologies’’ (which encompass both
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What is new?
 The need to maintain an up-to-date, dynamic sys-
tem for evidence synthesis can be facilitated using
new technologies which comprise both human and
machine effort.
 As well as standard review teams, systematic re-
view activities can be broken down into ‘‘micro-
tasks’’ and distributed across a wider group of
peopledincluding the involvement of citizen sci-
entists through crowdsourcing.
 Machine automation can assist with some system-
atic review tasks, including routine searching,
eligibility assessment, identification and retrieval
of full-text reports, extraction of data, and risk of
bias assessment.
 While the context is living systematic reviews,
many of these enabling technologies apply equally
to standard approaches to systematic reviewing.
computer technology and more efficient models of human
contribution) can increase the efficiency and sustainability
of the systematic review enterprise. We argue that human
effort is a scarce and valuable resource which should be ex-
pended only where automation is impossible, impractical,
or undesirable. Furthermore, for many of the repetitive
and labor-intensive tasks of evidence synthesis, automation
is increasingly preferable and viable [4e10]. Human effort
can contribute in two ways: either by undertaking tasks in a
specific review or by providing examples that can be used
to ‘‘train’’ machines which can then automate (or semi-
automate) the activity in questiondsometimes across many
reviews. We consider how human effort can be considered
not simply in terms of traditional author teams, but in terms
of communitiesdand ‘‘crowds’’dof people who come
together to curate knowledge in a given area. Rather than
organize the paper in terms of the two families of
technologiesdhuman and machinedwe consider each
stage of the systematic review process and discuss ways
in which these two technologies interact and operate in
mutually supportive ways.
2. Opportunities for a different workflow
Systematic reviews are conventionally undertaken by a
small team of trained researchers working in a highly la-
bor-intensivedbut time-limiteddway. New ways of work-
ing aim to replace this with a less labor-intensive model in
which the ongoing workflow is conducted by a wider com-
munity of individuals. The changes to review production we
describe here are not required for living systematic reviews
to be conducted, but are situated within a wider set of inno-
vations in evidence synthesis from which living systematic
reviews can draw to improve feasibility. For example, it is
possible that systematic review production will evolve away
from an individual, isolated endeavor, toward a dynamic and
continuous research curation system in which communities
of people work together to maintain an up-to-date evidence
base in their areas of interest. By breaking work into micro-
tasks, living systematic reviews may be conducted more
efficiently among a wider range of people. Microtasks are
discrete, small units of work, which can be done indepen-
dently from one another. We describe key living systematic
review microtasks alongside examples of new technologies
and innovative ways of working to help accomplish them in
Table 1. Breaking up the living systematic review workload
in this way allows the authorship team to take advantage of
emerging automation systems to reduce the workload. It
also makes more efficient use of the skill sets and time avail-
ability of contributors necessary for undertaking review
tasks. The formation of review teams can be assisted using
task-sharing platforms, such as Cochrane’s ‘‘Task Ex-
change’’ (taskexchange.cochrane.org/).
As Elliott et al. described [2], the work of a living sys-
tematic review begins with a traditional systematic review
(which can also benefit, of course, from many of the effi-
ciencies described here). We take the existence of the initial
systematic review as our starting point and outline below
Box 1 Series of papers on living systematic
reviews
 Living systematic reviews: 1. Introductiondthe
why, what, when, and how
 Living systematic reviews: 2. Combining human
and machine effort
 Living systematic reviews: 3. Statistical methods
for updating meta-analyses
 Living systematic reviews: 4. Living guideline
recommendations
Box 2 Living systematic reviews
 A systematic review which is continually updated,
incorporating relevant new evidence as it becomes
available
 An approach to review updating, not a formal re-
view methodology
 Can be applied to any type of review
 Use standard systematic review methods
 Explicit and a priori commitment to a predeter-
mined frequency of search and review updating
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the ways in which human and machine technologies can
work together to maintain the review as a living entity.
Throughout, we illustrate our argument with examples of
tools and processes. This is not intended to be an exhaustive
overview, and readers are referred to the Systematic Review
ToolBox (http://systematicreviewtools.com/) which indexes
a wide range of relevant tools.
2.1. Database searching and eligibility assessment
Identifying studies for inclusion is one of the most labor-
intensive and time-consuming tasks of the systematic re-
view process [11,12]. The component tasks include the
following: the searching of electronic bibliographic data-
bases, downloading the results, uploading them into soft-
ware for citation management, deduplicating records, and
screening them independently for eligibility. Guidance rec-
ommends that every citation is checked by two people to
reduce the possibility that studies will be missed by acci-
dent [13]. This standard process has remained largely un-
changed since systematic reviews first appeared.
2.1.1. Database searching
In a living systematic review, the search for biblio-
graphic material needs to be streamlined, changing the
traditional ‘‘pull’’ for bibliographic records (as carried out
within most systematic reviews) to a ‘‘push’’ model. In
the ‘‘push’’ model, automated searches are run regularly
and reviewers are alerted to the presence of new potentially
relevant research evidence (rather than needing to run
searches for themselves). A schematic showing how the
push model could work in practice is shown in Fig. 1.
The databases covered by these automated searches need
to cover the locations where relevant literature may be
found comprehensively and there are two potential limita-
tions in our current information infrastructure: (1) not all
databases support the regular running of specific searches
(i.e., auto-alerts); and (2) many databases do not offer an
open application programming interface (API) for third-
party software to connect to. Such software can, for
example, enable reviewers to conduct searches on these da-
tabases within bespoke systematic review software.
Systems which offer the possibility of regular compre-
hensive searches are emerging and include the Epistemoni-
kos database (epistemonikos.org, developed by the
Epistemonikos Foundation) and the Health Database
Advanced Search (HDASehdas.nice.org.uk/ddeveloped
by the National Institute for Health and Care Excellence).
These systems enable the user to search multiple databases
simultaneously: Epistemonikos by conducting its own
broad searches across a wide range of health databases
and adding results to a large corpus of health research;
and HDAS by using APIs to search multiple databases
when the user conducts a searchdor periodically, when
‘‘alerts’’ are set up.
In situations where a given database is necessary for a
living systematic review, but is not supported by the kinds
of services outlined previously, manual searching is
Table 1. The microtasks of a living systematic review, and how they may be automated or made more efficient
Review task Method/microtask Potential methods for efficiency gain
Team formation Use a wider range of personnel than may traditionally be
the case
Crowdsourcing (e.g., Cochrane Crowd)
Task-sharing platforms (e.g., TaskExchange)
Search Running search on bibliographic databases Automatic, continuous database search with push
notification
Database aggregators (e.g., HDAS, Epistemonikos)
Notification from clinical trial registries
Automatic retrieval of full-text papers (e.g., CrossRef)
Eligibility assessment Selecting studies for inclusion Machine-learning classifier
Crowdsourced inclusion decisions
Data extraction or collection Extracting information on characteristics of the
participants, interventions, outcomes
Machine-learning information-extraction systems (e.g.,
RobotReviewer, ExaCT)
Linkage of existing structured data sources (e.g.,
clinical trials registries)
Automated structured data extraction tools for PDFs
(e.g., ContentMine, Graph2Data)
Assessing risks of bias Machine learningeassisted risk of bias tools (e.g.,
RobotReviewer)
Synthesis Entering data into meta-analysis software Structured data extraction tools, which automatically
provide data in suitable format for statistical analysis
Conducting meta-analyses Continuous analysis updating based on availability of
structured extracted data
Report writing and updating conclusions Templated reporting of some report items
Statistical surveillance of key analysis results, with
threshold set for potential conclusion change
Supportive systems that reduce
duplication of effort
Data sharing and reuse Using standard descriptors for studies across all
systematic reviews (e.g., linkeddata.cochrane.org)
Abbreviation: HDAS, Health Database Advanced Search.
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necessarydwhich may be an opportunity for community
contribution. Because running a database search is a spe-
cific time-limited task that can be accomplished without
the expenditure of significant time if individuals are each
only responsible for one or two databases, the task of
searching can be distributed efficiently across multiple in-
dividuals. Thus, the manual searching of individual data-
bases and the downloading of search results are tasks that
can be assigned to people who may not be involved in
any other part of the living systematic review process.
The automated and manual search results can then be dedu-
plicated together, the process thus combining the effi-
ciencies of automation (where possible) with distributed
manual effort. This is not to say that specialist information
science expertise is not required because the creationdand
maintenancedof a good search strategy will always
require specialist human skills; but that, once a search
has been created, components of regularly running and
downloading results may be efficiently distributed across
a community.
2.1.2. Eligibility assessment
Once potentially relevant studies have been identified
through database searches and other sources, they need to
be checked for their eligibility to the review. Here a number
of human and machine enablers can contribute to the effi-
ciency of this process: generic classification, review-
specific classification, and crowdsourcing.
‘‘Text classification’’ is a standard machine-learning
problem in which the aim is to categorize texts (in this case,
biomedical texts) into groups of interest (here, citations that
do and do not meet the review’s inclusion criteria). When
used for eligibility assessment, text classification entails
the use of machine learning to exclude irrelevant citations
automatically. It usually operates on the titles and abstracts
of citations identified through database searches and pro-
vides a probability score that a given citation is, or is not,
of interest. Machine-learning classifiers need to ‘‘learn’’
from gold standard classifications, which have usually been
generated by human experts.
For example, the Cochrane Crowd, a citizen science
platform which enables anyone to contribute to reviews
via microtasks (see the following), has collectively classi-
fied over 415,000 records as to whether they describe a ran-
domized controlled trial (RCT) or not. These decisions
have been used to build a machine-learning model which
can predict how likely a new citation is to be describing
an RCT.
When trained with large amounts of high-quality data, as
in the case of the aforementioned RCT classifier, classifiers
can be very accurate. The RCT model, for example, is able
to exclude 60e80% of irrelevant records retrieved from a
database search while maintaining a sensitivity of over
99% [5]. The impact of this in a typical review is depicted
in Fig. 2. The area covered by the gray square depicts the
articles retrieved in the search and the yellow/orange rect-
angle the number of RCTs retrieved in that search. The
classifier can reduce the burden of screening for reviewers
to only those found in the pink rectangle, for the loss of less
Fig. 1. The push model for adding new evidence to a living systematic review. Note that once the system has been set up, the surveillance process
can run continuously and automatically without the need for manual intervention.
Fig. 2. Scaled rectangle diagram illustrating screening workload saved
when using the RCT classifier developed from the data annotated by
Cochrane Crowd. RCT, randomized controlled trial.
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than 1% of the RCTs retrieved. This is a nice example of a
human/machine workflow operating in mutually reinforc-
ing ways: as the Cochrane Crowd screens more citations,
the RCT Classifier can become more accurate; and as the
Classifier becomes more accurate, it is able to make the Co-
chrane Crowd more efficient, by removing from the process
those citations that are clearly not RCTs.
Thus, any given systematic review can take advantage of
the considerable workload savings that these ‘‘generic’’
classifiers offerdwhich aim to apply one or more of the
eligibility criteria of the review in question. For example,
a generic RCT classifier is suitable for use in all reviews
which only include RCTs but is unsuitable for use in re-
views which also include observational studies, as it would
eliminate these. The creation of generic classifiers requires
the existence of suitable training material.
At the time of writing, there are good classifiers avail-
able for RCTs [5], and members of the author team are
currently developing classifiers for systematic reviews and
economic evaluations; but there are no high-performing
classifiers to identify, for example, diagnostic test accuracy
studies because training data are not available. Thus, not all
systematic reviews will be able to take advantage of the
workload savings afforded using generic classification.
All is not lost though, as machine learning can assist
many systematic reviews through review-specific classifica-
tion. These are custom-built models that do not rely on
there being large amounts of data external to the review that
delineates its area of interest (i.e., the RCT example,
above). Instead, review-specific models learn directly from
the human screening decisions that were made when the
original review was conducted. Here, it is possible to build
a model that directly predicts the probability that a given
study is, or is not, relevant to the review. This is potentially
more specific to the review in question than the generic
classification example, as such a classifier would implicitly
combine the study-type specific classification (e.g., the
RCT classifier) with topic-specific classification (i.e., con-
dition, population, etc.). There are some important consid-
erations. First, the most significant drawback to using this
type of classifier is the lack of training data, although there
are techniques for using machine learning even in entirely
new reviews where humans and computers operate in a
workflow which prioritizes the relevant items for manual
screening while simultaneously improving the accuracy of
the machine model [14]. Even if reviewers have previously
considered, for example, 10,000 citations, this is far less
than might be used for building a generic classifier, and
its accuracy is likely to be lower. Second, it is difficult to
know how reliable the classifier will be when assessing
‘‘unseen’’ citations, as it will not have had the benefit of
‘‘seeing’’ the wide variety of relevant citations that might
be available. Thus, the generic classifiers are highly accu-
rate with respect to the task they have been trained to
perform (performing general categorizations), but they will
not be able to classify abstracts in a way that directly aligns
with the nuances of inclusion criteria defined by individual
reviews. By contrast, review-specific classifiers will tend to
be highly attuned to the context of the criteria for a review,
but may be less accurate, due to the lack of training mate-
rial. Both are developed by humans and machines operating
in mutually beneficial ways, illustrating one of the key
themes of this paper.
Automation is currently unable to perform the entirety
of eligibility assessment, and it is here that humans in the
form of ‘‘crowds’’ are particularly useful. In May 2016, Co-
chrane launched Cochrane Crowd, an online platform
where contributors can sign up to help identify and describe
health evidence (Fig. 3). To date, more than 6,000 people
have signed up and together have identified over 33,000 re-
ports of randomized controlled trials for Cochrane’s Central
register of controlled trials (CENTRAL). The Crowd is
supported by brief, interactive online training, and accuracy
is ensured using an agreement algorithm that requires each
record to be classified multiple times before it is either sub-
mitted to CENTRAL or rejected. Evaluations of Crowd
performance have shown 99% crowd sensitivity (the
Crowd’s ability to identify RCTs correctly) with respect
to a reference standard set of annotations, and 99% crowd
specificity (the Crowd’s collective ability to correctly iden-
tify the records that should be rejected).
Cochrane Crowd represents an important shift in the
way Cochrane seeks and manages information about
studies within the organization, as it facilitates a move
away from the traditional siloed approach to identifying ev-
idence on a peer-review basis, to an upstream model that
makes the best use of human effort, providing new oppor-
tunities for contributors to play a very real practical role
in managing the data deluge.
We should note that the performance metrics mentioned
previously have suggested that, for example, the recall of
99% of relevant citations may be ‘‘good enough’’ for the
purposes for a systematic review, and that this may be at
variance to an important principle of systematic reviews
that all relevant evidence should be included. It is true that,
in some reviews, even the loss of one study may change
conclusions, and so systems and processes which cannot
guarantee 100% recall need to be looked at critically. How-
ever, we would argue that compromises between what is
ideal and what is possible to achieve in terms of the breadth
of searches conducted are already part of systematic review
practice; that highly intensive human effort is unlikely to
result in perfect decisions, as humans make mistakes, espe-
cially when fatigued by significant time spent on repetitive
tasks; and that sensitive electronic searches are only one of
the ways in which eligible studies are identified. For these
reasons, we consider that the imperfect, but extremely high,
recall achieved in the aforementioned examples is likely to
be as good as, if not better, than that often achieved using
more conventional approaches.
After the titles and abstracts of potentially relevant
studies have been assessed, the full texts of reports are then
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retrieved for final selection and inclusion in the review;
again, humans and crowds can assist in this process.
Services such as the CrossRef API (http://search.crossref.
org/) can be used to automate the discovery of the locations
of full-text reports and papers and, although automation can
help, it often takes human effort and judgment to track
down all papers, and navigate permissions on subscription
content.
The assessment of full-text papers for inclusion in the re-
view is not a stage in the workflow where automation has
yet been developed, probably because the potential for
workload reduction here is so much less than is the case
for citation screening. The assessment of reports to check
whether they are relevant for the review is a task that can
be shared out across a distributed team though, thus keep-
ing any one individual’s workload to an acceptable
minimum.
Finally, the prospective identification of relevant studies
is increasingly possible thanks to the growth of data depos-
ited in trials registers, where studies are registered before
their commencement. In the future, systematic reviews
could benefit from an alerting mechanism to let members
know when a trial might be expected to reportdand
possibly communication with authors to ensure no relevant
papers are missed. The utilization of trial registries, such as
ClinicalTrials.gov, may be an important enabler for review
efficiency, given that they can contain quite detailed
outcome data, in a more structured and reanalyzable way
than publications. Although we may be some way off being
able to reuse outcome data in meta-analyses, having
detailed and machine-readable data on outcomes will
enable us, for example, to determine eligibility at a more
granular level and check for outcome reporting bias more
effectively.
2.2. Data extraction/collection and risk of bias
assessment
Once studies have been checked for their eligibility and
included in the review, information about the study,
including study characteristics and results data, needs to
be collected about them in a standardized way and their
risks of bias, relating to how they have been conducted
and assessed.
Automation technologies here are still being developed,
but they include the extraction of structured data from tables
and graphs in PDF files, thus saving time and also increasing
reliability (e.g., ContentMine, http://contentmine.org/ and
Graph2Data, https://github.com/EPPI-Centre/Graph2Data).
Assessment of the studies’ risk of bias can also be
partially automated, given sufficient human-created
training material, as exemplified by the RobotReviewer
tool, which can assess the risk of bias associated with RCTs
with an accuracy similar to that of humans [6]. RobotRe-
viewer has ‘‘learned’’ to apply the Cochrane Risk of Bias
tool (version 1) from more than 12,000 manually completed
assessments included in Cochrane reviews. The forth-
coming update of the Risk of Bias tool to version 2 presents
a challenge for future machine-learning tools because there
currently exist few (or no) human-conducted examples to
learn from; this may be another opportunity for a human-
machine workflow to be created, to develop training data
for automation, which then makes the manual task more
efficient in the future.
One option under consideration is whether automatic data
extraction (e.g., byRobotReviewer)might replace one of two
human reviewers (because many systematic review tasks are
performed in duplicate to reduce error and bias). This semi-
automation strategymight still substantially reduceworkload
Fig. 3. The Cochrane Crowd user interface.
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but leaves all output being manually verified. The impact of
such a strategy on efficiency and data accuracy is unclear.
The results of real-world pilot studies will help determine
how to best fit automation tools into the workflow.
2.3. Synthesis and reporting
Automation technologies exist for generating sections of
a review based on templates, based on its quantitative find-
ings (e.g., RevMan HAL: schizophrenia.cochrane.org/
revman-hal-v4). However, this area is very much under
development, and it is unlikely that most systematic re-
views will use this kind of automation. This said, there
may be a role for automation in determining whether a re-
view may need updating or should be prioritized for imme-
diate updating, by automatically identifying the number of
participants in the study (and, potentially, the direction of
its findings), and estimating how likely it is that a study
of its size would be able to change the result of the system-
atic review significantly. For example, if the review already
contained 80 trials, the appearance of one additional small
trial would be unlikely to alter the review’s conclusions; but
a large new trial in an analysis which did not contain many
studies might well require more urgent attention. (See also
paper 3 in this series for a discussion on specific statistical
issues relating to updating meta-analyses.)
In the future, systems that assist authors and peer re-
viewers will be of benefit to living systematic reviews,
and there are no fully developed systems yet available.
Important features include the automatic incorporation of
new studies in the appropriate analyses, and the ability to
highlight to authors and readers, those sections which have
recently changed. Such systems will also aid peer reviewers
in highlighting the newly incorporated data and enabling
them to focus their attention on the sections of the review
that have changed in the light of new evidence.
2.4. Looking ahead to new research evidence
surveillance systems
We have examined here the possibilities for human and
machines to contribute to the workflow in an individual
living systematic review. However, it may be that real
gains in efficiency will come when reviewers work
together at the research curation stage, developing mutu-
ally supportive systems that reduce duplication of effort
(e.g., a new study is assessed once for its relevance to mul-
tiple living systematic reviews). Critical here will be the
development not only of standards which enable systems
to interchange data efficiently (e.g., linkeddata.cochrane.
org/) but also of material and cultural incentives to share
research data openly for the public good. Fig. 1 reflects
the growing openness of trial data, in its inclusion of an in-
dividual participant data (IPD) repository, although we
should not allow a focus on IPD to obscure wider issues
of improving trial transparency [15].
3. Conclusion
We have provided an overview of the ways in which hu-
man and machine technologies can combine to create work-
flows that enable living systematic reviews to be
maintained with relatively limited time input from any
one individual. Automation technologies are ready for use
in the early stages of a living systematic reviewdin assess-
ing the eligibility of studies for inclusiondbut require
further research and development in the latter stages. While
the context for this series of papers is ‘‘living’’ systematic
reviews, many of these enabling technologies apply equally
to standard systematic reviews.
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